Role of Ayurveda Poly herbal granules "Punarnava Amritadi" on Thalassemia Major disease

â??Study on Punarnava Amritadi Granules as an Adjuvant in the Management of Beejadushtijanya Pandu with special reference to Thalassemia Majorâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020789

Enrollment

Registered

2019-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D561- Beta thalassemia

Interventions

Intervention1: Punarnava Amritadi Granules: Dose: 4.5 gm - 12.5 gm (for 4-15 years children) in two divided doses orally with milk, after food for 2 months Along with Standard Treatment protocol sim

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Thalassemia major between the age of 4-15 years, on regular blood transfusion and iron chelating therapy, Irrespective of sex, caste, religion & socio-economic background.

Exclusion criteria

Exclusion criteria: Complicated cases like HIV or HBV infection, Hepatic failure, Those requiring blood transfusion at an interval of 15 days or less.

Design outcomes

Primary

Measure	Time frame
Changes in the lakshanas of Pandu, To increase the period between Blood Transfusions &To reduce iron over load (Iron chelation).Timepoint: 2 months	—

Secondary

Measure	Time frame
Biochemical, Hematological investigation.Timepoint: 2 months	—

Countries

India

Contacts

Public ContactChetan Bhalkar

Mahatma Gandhi Ayurved College Hospital & Research Centre

dr.srihari@rediffmail.com7709898904

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026